HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leber Congenital Amaurosis: Genotypes and Retinal Structure Phenotypes.

Abstract
Leber congenital amaurosis (LCA) patients of 10 known genotypes (n = 24; age range, 3-25 years) were studied clinically and by optical coherence tomography (OCT). Comparisons were made between OCT results across the horizontal meridian (central 60(o)) of the patients. Three patterns were identified. First, there were LCA genotypes with unusual and readily identifiable patterns, such as near normal outer nuclear layer (ONL) across the central retina or severely dysplastic retina. Second, there were genotypes with well-formed foveal architecture but only residual central islands of normal or reduced ONL thickness. Third, some genotypes showed central ONL losses or dysmorphology suggesting early macular disease or foveal maldevelopment. Objective in vivo morphological features could complement other phenotypic characteristics and help guide genetic testing of LCA patients or at least permit a differential diagnosis of genotypes to be made in the clinic.
AuthorsSamuel G Jacobson, Artur V Cideciyan, Wei Chieh Huang, Alexander Sumaroka, Hyun Ju Nam, Rebecca Sheplock, Sharon B Schwartz
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 854 Pg. 169-75 ( 2016) ISSN: 0065-2598 [Print] United States
PMID26427408 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Alleles
  • Child
  • Child, Preschool
  • Female
  • Fovea Centralis (metabolism, pathology)
  • Genotype
  • Humans
  • Leber Congenital Amaurosis (classification, genetics, pathology)
  • Male
  • Phenotype
  • Retina (metabolism, pathology)
  • Tomography, Optical Coherence (methods)
  • Visual Acuity
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: